Floatz logo

Capsaicin

Hyperalgesia

National Institute of Dental and Craniofacial Research (NIDCR)Small moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Hyperalgesia cohort.

Asset / SponsorPhaseRating
FENTANYL
University Hospital, Ghent
Phase 4BB
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Barts & The London NHS Trust
Phase 4BB
Pregabalin
Barts & The London NHS Trust
Phase 4BB
Nefopam
University Hospital, Bordeaux
Phase 2/3B
Néfopam
University Hospital, Bordeaux
Phase 2/3B

View all 12 →

Same molecule, other indications

Capsaicin is also rated in:

peripheral nervous system disorderDormant
A
Indicative ·
81 / 100
View asset →
diabetic neuropathyDormant
BBB
Indicative ·
78 / 100
View asset →
postherpetic neuralgiaDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →